Healthcare, biotechnology & medical AI Product
Galen Second Read flags prostate biopsy slides for another review
Ibex Medical Analytics’ Galen Second Read identifies specified digital prostate biopsy cases initially read as benign that may warrant another look by a pathologist. [1]
- Release status
- U.S. FDA 510(k) clearance K241232, decided January 24, 2025. [1]
What it does
The FDA cleared Galen Second Read under 510(k) K241232 on January 24, 2025, as a Class II software device for digital pathology. [1]
Why it matters
The filing documents a second-read role after a pathologist’s initial evaluation. The output can direct attention to cases and areas of a slide for further review. [1]
Who it’s for
The labeled use concerns pathologists reviewing digital images of the specified prostate biopsy slides. [1]
Key dates
- FDA clears Galen Second Read [1]
Where it fits
The product flags cases and slides and can display a heatmap of suspicious tissue using images digitized by the named Philips Ultra Fast Scanner. [1]
Limits and trade-offs
The indication applies to the listed tissue, scanner and review workflow. The software provides a second-read aid. [1]
Sources and verification
Catalog evidence checked How we verify records
- Primary source FDA 510(k) decision for Galen™ Second Read™ (K241232)
Related profiles
Healthcare, biotechnology & medical AI
Sleep Analysis Module (SAM)
Neurotronics (Nihon Kohden)
The module estimates sleep time from a signal captured during its intended sleep-testing workflow.
Healthcare, biotechnology & medical AI
Heartvue.Proton
Heartvue.ai
It is software for analyzing cardiac MRI images within its documented intended-use scope.
Healthcare, biotechnology & medical AI
ThinkSono Guidance
ThinkSono
Provides guidance during acquisition of lower-extremity compression ultrasound images for review by healthcare professionals.